Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by S. Müller-Hagen
Monitoring Ovarian Carcinoma With CA 125, CA 19–9, CA 15–3 and CEA in Serum, Ascites and Tumor Tissue
Journal of Cancer Research and Clinical Oncology
Medicine
Cancer Research
Oncology
Related publications
CA 19-9 and CA 125 Determination by Immunoluminometric Assay
Clinical Chemistry and Laboratory Medicine
Biochemistry
Medicine
Clinical Biochemistry
CA 72-4 Compared With Cea and CA 19-9 as a Marker of Some Gastrointestinal Malignancies
International Journal of Biological Markers
Oncology
Cancer Research
Clinical Biochemistry
Forensic Medicine
Medicine
Pathology
Serum McA, CA 125 and CA 19.9 Determination in Primary Breast Cancer
Biochemical Society Transactions
Biochemistry
Elevated Serum CA 19-9 Levels in Dermoid Cyst: A Predictor of Ovarian Torsion and Tissue Necrosis?
International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Tumor Markers CA 125 and CA 19–9 in Cord Blood and During Infancy: Developmental Changes and Use in Pediatric Germ Cell Tumors
Pediatric Research
Child Health
Pediatrics
Perinatology
Prognostic Value of Monitoring Tumour Markers CA 15-3 and CEA During Fulvestrant Treatment
BMC Cancer
Cancer Research
Oncology
Genetics
Increased Serum CA 19-9 Antibodies in Sjogren's Syndrome.
Postgraduate Medical Journal
Medicine
Clinical Evaluation of Tumor Markers CA 19-9 and CA 125 in Diseases of the Digestive System: Diagnostic Usefulness Especially in Carcinoma of the Pancreas and Biliary Tract.
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Tumour-Associated Trypsin Inhibitor (TATI) in Human Ovarian Cyst Fluid. Comparison With CA 125 and CEA
British Journal of Cancer
Cancer Research
Oncology
